{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

4012S2_04_CVT-Pro-Arrhythmia-1

4012S2_04_CVT-Pro-Arrhythmia-1 - CP-1 Surrogate Markers of...

Info iconThis preview shows pages 1–6. Sign up to view the full content.

View Full Document Right Arrow Icon
CP-1 Surrogate Markers of Pro-Arrhythmic Risk Peter Kowey, MD, FACC Mainline Heart Health Center
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
CP-2 QT Risk Assessment Comprehensive preclinical assessment
Background image of page 2
CP-3 Myocardial Wedge Preparation QT interval Transmural dispersion of repolarization (TDR) Early afterdepolarizations (EADs)
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
CP-4 Specific Drugs in the Myocardial Wedge Preparation QT TDR EAD d-Sotalol + + + Dofetilide + + + Cisapride + + + Terfenadine + + + Moxifloxacin
Background image of page 4
Background image of page 5

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full Document Right Arrow Icon
Background image of page 6
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}